• Intermittent Claudication: Characterized by pain, cramping, or heaviness in the legs or buttocks during physical activities ...

We read with interest the Article by Marc P Bonaca and colleagues, which showed that the GLP-1 receptor agonist semaglutide improves walking distance by 13% in patients with peripheral artery disease ...

AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral vascular disorders, today announced the launch of the U.S. Food and Drug ...

The mechanism remains unclear, but GLP-1 users had less MACE, CV death, and all-cause death driven by fewer amputations.

The Freeman Screen Team offers ultrasound screenings to assess cardiovascular health risks, including stroke, peripheral ...

MIAMI BEACH, FL—Intravascular imaging deserves a larger role in peripheral vascular interventions, according to a newly released consensus opinion of leaders spanning the many specialties involved in ...

The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound impact on prevention, diagnosis, treatment and outcomes for women, ...

In patients with peripheral artery disease, radial artery access is safe and feasible for peripheral vascular intervention. Radial artery access is safe and feasible for peripheral vascular ...

Add Yahoo as a preferred source to see more of our stories on Google. It’s no secret that as we get older, our bodies start to react differently to the same activities. Clutching the pages of a ...

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...

Abbott Laboratories, has acquired Walk Vascular LLC, a deal that brings two devices for peripheral thrombectomy to the Abbott portfolio for peripheral artery disease (PAD). Walk’s two Jeti peripheral ...

Fluoropolymer specialist targets peripheral vascular device makers with expanded liner diameters at MD&M West 2026.